2019 Nobel Prize in Physiology or Medicine awarded for how cells sense and adapt to oxygen availability

11th October 2019

The Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza "for their discoveries of how cells sense and adapt to oxygen availability."

Source: NobelPrize.org

2017 Nobel Prize for Biological Clock

2nd October 2017

The Nobel Assembly at Karolinska Institutet has today decided to award the 2017 Nobel Prize in Physiology or Medicine jointly to Jeffrey C. Hall, Michael Rosbash and Michael W. Young for their discoveries of molecular mechanisms controlling the circadian rhythm.

Source: Nobelprize.org

Personalized cancer vaccines show glimmers of success

7th July 2017

Treatments tailored to a person's individual cancer mutations train immune system to attack tumours

Source: Nature News

Oxford Nanopore’s Hand-Held DNA Analyzer Has Traveled the World

30th June 2017

A British company bets a hand-held analyzer will change how we look at DNA.

Source: MIT Technology Review

Roche’s emicizumab cuts bleed rate by 87% in hemophilia A

28th June 2017

Roche has released a closer look at the data it hopes will propel hemophilia A drug emicizumab to blockbuster status. Emicizumab cut the bleed rate by 87%

Source: Fierce Biotech

Bionik Labs joins forces with Wistron on low-cost exoskeleton tech

28th June 2017

Robotics player Bionik Laboratories has inked a joint development deal with Wistron Corporation to create and commercialize affordable exoskeleton products for the lower body.

Source: Fierce Biotech

European biotech fund hits $74M, looks to build on previous successes

28th June 2017

The third BioGeneration Ventures Fund has gone over its €50 million target and hit €66 million ($74 million) as it attracts new investors.

Source: Fierce Biotech

China’s genomics giant to make stock-market debut

28th June 2017

BGI in Shenzhen has shifted its focus from serving researchers to medical applications of genome sequencing.

Source: Nature News

FDA Approval of Drug May Have Made This Bay Area Pharma a New M&A Target

28th June 2017

Could the Bay Area’s Portola Pharmaceuticals (PTLAN) be the next hot acquisition target? Recent good news has upped the company’s market value

Source: Biospace News

Modified viruses deliver death to antibiotic-resistant bacteria

28th June 2017

Genetically modified viruses that cause bacteria to kill themselves could be the next step in combating antibiotic-resistant infections.

Source: Nature News

©2019 E3 Life AG

E3 Life AG, Grafenaustr. 5, 6302 Zug, Switzerland
getintouch@e3-life.com